Xiang Wu | Medical Biomaterials | Research Excellence Award

Dr. Xiang Wu | Medical Biomaterials | Research Excellence Award

Ningbo University | China

Dr. Xiang Wu is a dedicated medical researcher and clinician currently serving at Ningbo Medical Center Li Huili Hospital, Health Science Center, Ningbo University, where he actively contributes to interdisciplinary biomedical research. With a strong academic foundation in medical sciences and biomaterials, his education and professional training have enabled him to bridge clinical needs with engineering-driven solutions. His experience spans hospital-based research and university-level scientific collaboration, focusing on translating laboratory innovations into practical medical applications. Dr. Wu’s primary research interests include functional hydrogels for tissue adhesion, hemostasis, postoperative repair, and advanced biomaterials such as bone and joint materials, adhesive systems, and Janus patches. In parallel, he investigates molecular regulatory mechanisms involving lncRNA and circRNA in cancers, particularly pancreatic and bladder cancer, highlighting his integrative approach that combines materials science with molecular medicine. Since 2020, his scholarly contributions have gained notable academic recognition, reflected in a strong citation record and h-index, underscoring the impact of his research on addressing clinical treatment challenges. His work aligns closely with modern translational medicine, emphasizing innovation, clinical relevance, and interdisciplinary collaboration. In conclusion, Dr. Wu represents a new generation of clinician-scientists whose research advances both biomedical materials and molecular oncology, contributing meaningfully to improved therapeutic strategies and future medical technologies.

Profiles: Orcid | Google Scholar

Featured Publications

 

Radwa Mahmoud | Biotechnology | Excellence in Research Award

Ms. Radwa Mahmoud | Biotechnology | Excellence in Research Award

Biotechnology Department, Faculty of Science, Cairo University, Egypt

Ms. Radwa Mahmoud is an emerging biotechnology researcher with strong expertise in cancer therapeutics, molecular diagnostics, and nanoparticle biosynthesis. She is currently pursuing a Master’s degree in Biotechnology at Cairo University, where she previously completed her Bachelor’s degree with distinction, ranking among the top students. Her research interests span breast cancer treatment using scorpion-venom-derived peptides, CRISPR-based microbiome engineering, antimicrobial peptides, and the biomedical applications of nanomaterials. Radwa has extensive hands-on experience in wet-lab experimentation, diagnostic assay design, cytotoxicity analysis, molecular cloning, protein purification, and computational modeling. She has led multidisciplinary research projects focused on early breast cancer detection and innovative therapeutic models, earning competitive funding support from the Science and Technology Development Fund (STDF) and winning awards such as Best Poster at SOLE and a Silver Medal at the international iGEM competition. Her professional experience includes roles in pharmaceutical research and development, molecular biology laboratories, and academic teaching support. Radwa’s growing publication record and contributions to translational research highlight her commitment to advancing oncology, biotechnology innovation, and therapeutic discovery. She aims to continue developing impactful scientific solutions addressing global health challenges.

Profiles: Scopus | Orcid

Featured Publications

Amen, R.A. (2024). “Harnessing plant extracts for skin health and dermatological care: herbal wonders green solutions” in Herbal Wonders Green Solutions.

Amen, R.A. (2024). “Therapeutic potential and characteristics of Smp43 peptide (scorpion venom) and its interaction with cellular signaling pathways: a review” in Review.

Amen, R.A. (2024). “Exploring the potential of natural compounds in cancer treatment: a review” in Review.

Amen, R.A. (2024). “Coinfection of schistosomiasis and hepatitis C in Egypt: challenges and possible management strategies” in Review.

Amen, R.A. (2024). “Biosynthesis of silver, copper, and their bi-metallic nanocomposites by Staphylococcus aureus: their antimicrobial, anticancer activity, and cytotoxicity effect” in Journal Article.

Amen, R.A. (2023). “COVID-19 omicron variant: variation from other variants, immune response, and vaccination against this rapidly spreading pandemic” in Review.

Amen, R.A. (2022). “Pharmacological properties of 4′, 5, 7-trihydroxyflavone (apigenin) and its impact on cell signaling pathways” in Review.

Dr. Hongyan Lin | Pharmaceutical Chemistry | Best Researcher Award

Dr. Hongyan Lin | Pharmaceutical Chemistry | Best Researcher Award

Changzhou University | China

Dr. Hongyan Lin is a distinguished researcher and lecturer at the School of Pharmaceutical Sciences, Changzhou University, China, with a strong emphasis on natural product chemistry and molecular pharmacology. She completed her Bachelor’s degree in Bioengineering at Changzhou University, followed by an Integrated Master-PhD in Biology at Nanjing University, where she specialized in the biological mechanisms of traditional medicine. Dr. Lin further expanded her expertise as a Postdoctoral Fellow and Research Associate at the School of Life Sciences, Nanjing University, contributing significantly to molecular pharmacology and natural product research. Her research interests focus on the chemical structural modification of natural products for anticancer applications, the role of traditional Chinese medicine in regulating intestinal microbiota to prevent colitis-associated cancer, and the isolation, structural identification, and biological activity of bioactive compounds from traditional herbs. Dr. Lin has been recognized for her scientific contributions through research grants and academic publications in high-impact journals. Her work supports the evolution of natural product-based therapeutics and offers promising directions for cancer prevention and treatment. In her role as a lecturer and researcher, she continues to inspire the next generation of pharmaceutical scientists through her dedication and innovation.

Profiles: Scopus | Orcid

Featured Publications

Lin, H., Ai, D., Liu, Q., Wang, X., Gao, J., Chen, Q., Ruan, L., Tao, Y., Gao, J., & Wang, L. (2023). Modified Podophyllotoxin Phenoxyacetamide Phenylacetate Derivatives: Tubulin/AKT1 Dual-Targeting and Potential Anticancer Agents for Human NSCLC. Journal of Natural Products, Published online July 28, 2023.

Lin, H., Zhou, Z., Ma, X., Chen, Q., Han, H., Wang, X., Qi, J., & Yang, Y. (2021). One pot synthesis of aryl nitriles from aromatic aldehydes in a water environment. RSC Advances, 2021.